Literature DB >> 10907115

Increased fetal leptin in type I diabetes mellitus pregnancies complicated by chronic hypoxia.

T K Hytinantti1, H A Koistinen, K Teramo, S L Karonen, V A Koivisto, S Andersson.   

Abstract

AIMS/HYPOTHESIS: The purpose of this study was to examine whether fetal leptin concentration correlates with severity of chronic or subchronic fetal hypoxia as indicated by increased fetal concentrations of erythropoietin in fetuses of mothers with Type I (insulin dependent) diabetes mellitus.
METHODS: We measured leptin and erythropoietin concentrations in cord plasma and amniotic fluid with radioimmunoassay in 25 pregnancies (gestational age 37.2 +/- 1.0 weeks). Fetuses with amniotic fluid erythropoietin over 22.5 mU/ml were classified as hypoxic (n = 9) and those with amniotic fluid erythropoietin below 22.5 mU/ml (n = 16) as non-hypoxic.
RESULTS: The hypoxic fetuses had significantly higher cord leptin concentrations than non-hypoxic fetuses (median 36.8; range, 12.5-135.1 vs median 16.2; range, 3.7-52.2 micrograms/l), (p = 0.0066). Cord plasma leptin (n = 25) correlated directly with amniotic fluid erythropoietin (r = 0.727, p = 0.0001), with cord plasma erythropoietin (r = 0.644, p = 0.0005) and with the maternal last trimester HbA1C (r = 0.612, p = 0.0019) and negatively with cord artery pO2 (r = -0.440, p = 0.032), and pH (r = -0.414, p = 0.040). CONCLUSION/
INTERPRETATION: Fetal leptin concentrations increased concomitantly with erythropoietin during chronic or subchronic hypoxia. This phenomenon could indicate a role for leptin in fetal adaptation to hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10907115     DOI: 10.1007/s001250051367

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  3 in total

1.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

Review 2.  Glucose, insulin, and oxygen interplay in placental hypervascularisation in diabetes mellitus.

Authors:  Silvija Cvitic; Gernot Desoye; Ursula Hiden
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

Review 3.  Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus.

Authors:  Luis Sobrevia; Rocío Salsoso; Bárbara Fuenzalida; Eric Barros; Lilian Toledo; Luis Silva; Carolina Pizarro; Mario Subiabre; Roberto Villalobos; Joaquín Araos; Fernando Toledo; Marcelo González; Jaime Gutiérrez; Marcelo Farías; Delia I Chiarello; Fabián Pardo; Andrea Leiva
Journal:  Front Physiol       Date:  2016-03-31       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.